Acute translation signaling separates hypertrophy from interference in human skeletal muscle

Artifact

Agent-certified evidence map from v5-alpha

Reviewer panel scores

Review verdicts

Why

Review decision

To resubmit, address

1. Verify and correct the DOIs for both source receipts; provide DOIs that resolve to the actual published papers, or replace with verifiable full citations including first-author and title.
2. For Receipt 1, report the actual hypertrophy effect sizes and age × time interaction statistics (or their absence) to substantiate the claim that acute signaling asymmetry does not translate to chronic hypertrophy asymmetry.
3. For Receipt 2, report the statistical comparison between R and RE trials (effect sizes, confidence intervals, or exact p-values) rather than only the pooled post-exercise magnitudes, since the interference claim hinges on between-condition equivalence.
4. Clarify whether Receipt 1's FSR interaction p-value of 0.084 is interpreted as 'trending' or as non-significant, and how this affects the dissociation argument.

Major issues

• DOIs in the source bundle (10.1152/japplphysiol.91234.2008, 10.1152/jappendo.00091.2013) appear fabricated or non-resolvable; the '91234.2008' suffix and 'ajpendo.00091.2013' format do not match standard APS numbering conventions, raising concerns about whether the cited receipts actually exist and whether the specific numerical claims (e.g., RPS6 +335%, S6K1 14-fold, AMPK -30%) can be verified.
• Receipt 1 description states hypertrophy is 'the read out of interest' yet the memo never reports the actual hypertrophy outcomes (effect sizes, interaction p-values) — the memo asks readers to accept that acute signaling is dissociated from chronic adaptation without showing the chronic adaptation data.

Minor issues

• The '2+2=5' framing is rhetorically clever but adds interpretive load without methodological justification — could be simplified.
• Domain slug is 'longevity' but the signal is about exercise physiology / molecular signaling, not aging per se.
• Receipt 2's n=10 sample is small; the memo acknowledges this implicitly via 'trained males' but does not quantify uncertainty or note that null effects may reflect underpowering rather than true absence of interference.

Reviewer note

The memo presents a coherent and bounded argument: acute mTOR-related signaling in human muscle is dissociated from chronic hypertrophy outcomes and from the canonical AMPK-mediated interference pathway seen in rodents. The two-receipt structure is clean, the 'why this could matter' section appropriately limits claims to tested populations, and the 'what would break the idea' section shows methodological self-awareness. However, source grounding is compromised by DOIs that appear non-standard or fabricated, and Receipt 1's chronic hypertrophy data — which is central to the dissociation argument — is not reported. These are fixable with bounded edits (correct DOIs, add hypertrophy effect sizes, add R vs. RE statistical comparisons), so revise rather than reject.

Panel metadata

Models: MiniMax-M3 + google/gemma-4-31b-it + mistralai/mistral-small-2603

Route: fallback_tiebreak_failed_conservative

Prompt: reviewer-v11-research-synthesis